Lisa Iversen

Lisa Iversen

Auto-generated profile, based on publicly available information

Lisa Iversen

Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2017 in New England Journal of Medicine
Verified
Journal Article
Closed access
LMLina S. Mørch
Lina S. Mørch
CSCharlotte W. Skovlund
Charlotte W. Skovlund
PHPhilip C. Hannaford
Philip C. Hannaford
LILisa Iversen
Lisa Iversen
SFShona Fielding
Shona Fielding
ØLØjvind Lidegaard
Øjvind Lidegaard
Little is known about whether contemporary hormonal contraception is associated with an increased risk of breast cancer.

11 September 2007 in BMJ
Verified
Journal Article
Closed access
PDF file
PHPhilip C Hannaford
Philip C Hannaford
SSSivasubramaniam Selvaraj
Sivasubramaniam Selvaraj
AEAlison M Elliott
Alison M Elliott
VAValerie Angus
Valerie Angus
LILisa Iversen
Lisa Iversen
ALAmanda J Lee
Amanda J Lee
Objective To examine the absolute risks or benefits on cancer associated with oral contraception, using incident data.Design Inception cohort study. Setting Royal College of General Practitioners' oral contraception study.Participants Directly standardised data from the Royal College of General Practitioners' oral contraception study.Main outcome measures Adjusted relative risks between never and ever users of oral contraceptives for different types of cancer, main gynaecological cancers combined, and any cancer. Standardisation variables were age, smoking, parity, social class, and (for the general practitioner observation dataset) hormone replacement therapy. Subgroup analyses examined whether the relative risks changed with user characteristics, duration of oral contraception usage, and time since last use of oral contraception.Results The main dataset contained about 339 000 woman years of observation for never users and 744 000 woman years for ever users. Compared with never users ever users had statistically significant lower rates of cancers of the large bowel or rectum, uterine body, and ovaries, tumours of unknown site, and other malignancies; main gynaecological cancers combined; and any cancer. The relative risk for any cancer in the smaller general practitioner observation dataset was not significantly reduced. Statistically significant trends of increasing risk of cervical and central nervous system or pituitary cancer, and decreasing risk of uterine body and ovarian malignancies, were seen with increasing duration of oral contraceptive use. Reduced relative risk estimates were observed for ovarian and uterine body cancer many years after stopping oral contraception, although some were not statistically significant. The estimated absolute rate reduction of any cancer among ever users was 45 or 10 per 100 000 woman years, depending on whether the main or general practitioner observation dataset was used.Conclusion In this UK cohort, oral contraception was not associated with an overall increased risk of cancer; indeed it may even produce a net public health gain. The balance of cancer risks and benefits, however, may vary internationally, depending on patterns of oral contraception usage and the incidence of different cancers.

1 June 2017 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
LILisa Iversen
Lisa Iversen
SSSelvaraj Sivasubramaniam
Selvaraj Sivasubramaniam
ALAmanda J. Lee
Amanda J. Lee
SFShona Fielding
Shona Fielding
PHPhilip C. Hannaford
Philip C. Hannaford
Oral contraceptives have been used by hundreds of millions of women around the world. Important questions remain regarding the very long-term cancer risks that are associated with oral contraception. Despite previous research, important questions remain about the safety of these contraceptives: (1) How long do endometrial, ovarian, and colorectal cancer benefits persist? (2) Does combined oral contraceptive use during the reproductive years produce new cancer risks later in life? (3) What is the overall balance of cancer among past users as they enter the later stages of their lives? The purpose of this study was to examine the very long-term cancer risks or benefits associated with the use of combined oral contraceptives, including the estimated overall life-time balance. The 46,022 women who were recruited to the UK Royal College of General Practitioners' Oral Contraception Study in 1968 and 1969 were observed for up to 44 years. Directly standardized rates of specific and any cancer were calculated for "ever" and "never" users of combined oral contraceptives; data were standardized for age, parity, social class, and smoking. Attributable risk and preventive fraction percentages were calculated. Poisson regression that adjusted for the same variables was used to estimate incidence rate ratios between ever and never users and to examine effects by time since last oral contraceptive use. There were 4661 ever users with at least 1 cancer during 884,895 woman-years of observation and 2341 never users with at least 1 cancer during 388,505 woman-years of observation. Ever use of oral contraceptives was associated with reduced colorectal (incidence rate ratio, 0.81; 99% confidence interval, 0.66-0.99), endometrial (incidence rate ratio, 0.66; 99% confidence interval, 0.48-0.89), ovarian (incidence rate ratio, 0.67; 99% confidence interval, 0.50-0.89), and lymphatic and hematopoietic cancer (incidence rate ratio, 0.74; 99% confidence interval, 0.58-0.94). An increased risk of lung cancer was seen only among ever users who smoked at recruitment. An increased risk of breast and cervical cancer that was seen in current and recent users appeared to be lost within approximately 5 years of stopping oral contraception, with no evidence of either cancer recurring at increased risk in ever users with time. There was no evidence of new cancer risks appearing later in life among women who had used oral contraceptives. Thus, the overall balance of cancer risk among past users of oral contraceptives was neutral with the increased risks counterbalanced by the endometrial, ovarian, and colorectal cancer benefits that persist at least 30 years. Most women who choose to use oral contraceptives do not expose themselves to long-term cancer harms; instead, with some cancers, many women benefit from important reductions of risk that persist for many years after stopping.

11 March 2010 in BMJ
Verified
Journal Article
Open access
PHP. C Hannaford
P. C Hannaford
LIL. Iversen
L. Iversen
TMT. V Macfarlane
T. V Macfarlane
AEA. M Elliott
A. M Elliott
VAV. Angus
V. Angus
ALA. J Lee
A. J Lee
Read the full review for this F1000Prime recommended article: Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study.

9 May 2016 in British Journal of General Practice
Verified
Journal Article
Open access
PDF file
HRHelen D Robertson
Helen D Robertson
AEAlison M Elliott
Alison M Elliott
CBChristopher Burton
Christopher Burton
LILisa Iversen
Lisa Iversen
PMPeter Murchie
Peter Murchie
CMCatriona Matheson
Catriona Matheson
Background Modern demands and challenges among healthcare professionals can be particularly stressful and resilience is increasingly necessary to maintain an effective, adaptable, and sustainable workforce. However, definitions of, and associations with, resilience have not been examined within the primary care context. Aim To examine definitions and measures of resilience, identify characteristics and components, and synthesise current evidence about resilience in primary healthcare professionals. Design and setting A systematic review was undertaken to identify studies relating to the primary care setting. Method Ovid®, Embase®, CINAHL, PsycINFO, and Scopus databases were searched in December 2014. Text selections and data extraction were conducted by paired reviewers working independently. Data were extracted on health professional resilience definitions and associated factors. Results Thirteen studies met the inclusion criteria: eight were quantitative, four qualitative, and one was an intervention study. Resilience, although multifaceted, was commonly defined as involving positive adaptation to adversity. Interactions were identified between personal growth and accomplishment in resilient physicians. Resilience, high persistence, high self-directedness, and low avoidance of challenges were strongly correlated; resilience had significant associations with traits supporting high function levels associated with demanding health professional roles. Current resilience measures do not allow for these different aspects in the primary care context. Conclusion Health professional resilience is multifaceted, combining discrete personal traits alongside personal, social, and workplace features. A measure for health professional resilience should be developed and validated that may be used in future quantitative research to measure the effect of an intervention to promote it.

9 May 2016 in British Journal of General Practice
Verified
Journal Article
Open access
PDF file
CMCatriona Matheson
Catriona Matheson
HRHelen D Robertson
Helen D Robertson
AEAlison M Elliott
Alison M Elliott
LILisa Iversen
Lisa Iversen
PMPeter Murchie
Peter Murchie
Background The modern primary healthcare workforce needs to be resilient. Early research framed professional resilience as avoiding ‘burnout’; however, more recent literature has introduced the concept of positive adaptation to professional challenges, which results in individuals thriving in their role. Aim To explore what primary health professionals working in challenging environments consider to be characteristics of resilience and what promotes or challenges professional resilience. Design and setting A qualitative focus group in north east Scotland. Method Five focus groups were held with 20 health professionals (six GPs, nine nurses, four pharmacists, and a practice manager) based in rural or deprived city areas in the north east of Scotland. Inductive thematic analysis identified emerging themes. Results Personal resilience characteristics identified were optimism, flexibility and adaptability, initiative, tolerance, organisational skills, being a team worker, keeping within professional boundaries, assertiveness, humour, and a sense of self-worth. Workplace challenges were workload, information overload, time pressures, poor communication, challenging patients, and environmental factors (rural location). Promoters of professional resilience were strong management support, teamwork, workplace buffers, and social factors such as friends, family, and leisure activities. Conclusion A model of health professional resilience is proposed that concurs with existing literature but adds the concept of personal traits being synergistic with workplace features and social networks. These facilitate adaptability and enable individual health professionals to cope with adversity that is inevitably part of the everyday experience of those working in challenging healthcare environments.